What is FotoFacial™?
FotoFacial™ is a new and unique aesthetic procedure. Using a series of full face intense pulsed light treatments, erythema (redness of the skin) and flushing of the face, neck and chest can be successfully treated. In addition, treatment improves the visible signs of photoaging and rosacea by reducing fine wrinkles, enlarged pores, telangiectasias (dilated capilaries) and irregular pigmentation.

How can I determine if this treatment
is right for me?
To know if you are a candidate for FotoFacial™ treatment, a trained physician or nurse must evaluate you. The Laser Light Treatment Center has trained personnel and offers complimentary consultations. Currently, FotoFacial™ is the newest, most exciting and effective treatment for the visible signs of rosacea. Most patients can stop using antibiotics and medicated creams.

What is the treatment like?
FotoFacial™ consists of five, thirty to forty five minute, treatments spaced three weeks apart. Intense pulsed light is passed along the skin of the face, and in some instances, neck and chest. Patients describe the sensation as feeling like the snap of a rubber band.

When will I be able to return to my
normal activities?
Patients experience NO DOWN TIME. However, it is best to plan to put ice on the treated area for at least 20 minutes or longer after treatment. This reduces redness and swelling. In most instances, normal activities can be resumed immediately.

What kind of results can be expected?
In a recent study using specific pulse parameters and fluence in performing FotoFacial™, patients showed overall improvement and 90% showed "much" to "very much" improvement in signs and symptoms of rosacea. The greatest improvements were seen in facial flushing (89% improvement); facial erythema (86% improvement); telangiectasias (84% improvement); irregular pigmentation (84% improvement) and fine wrinkles (84% improvement). In addition, skin coarseness was improved 74% and pore size was improved 49%. Patients had 92% improvement in the inflammatory lesions of rosacea. Treatments were tolerated with no patient down time in 10 1 of 103 total treatments. Treatment results were accomplished with minimal temporary adverse effects.